Showing results (11-20 of 6,496) with videos related to
Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|March 21, 2020
Sero-prevalence of rubella among pregnant women in Sub-Saharan Africa: a meta-analysisZemenu Yohannes Kassa, Siraj Hussen, Solomon AsnakeHuman Vaccines & Immunotherapeutics|September 11, 2020
Coronavirus disease 2019 (COVID-19) in domestic animals and wildlife: advances and prospects in the development of animal models for vaccine and therapeutic researchKhan Sharun, Ruchi Tiwari, Shailesh Kumar Patel, et al.Human Vaccines & Immunotherapeutics|June 15, 2021
A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in childrenNilesh Gujar, Muralidhar Tambe, Malangori Parande, et al.Human Vaccines & Immunotherapeutics|June 15, 2021
Implementation of a program to improve influenza vaccination rates among medical students: a comparative study involving two university affiliated hospitalsMiguel Saro-Buendía, Ángel Marrero-Sánchez, Daniel García-Ruiz de Morales, et al.Human Vaccines & Immunotherapeutics|May 27, 2021
Preliminary evidence on the safety profile of BNT162b2 (Comirnaty): new insights from data analysis in EudraVigilance and adverse reaction reports from an Italian health facilityMichele Gringeri, Giulia Mosini, Vera Battini, et al.Human Vaccines & Immunotherapeutics|May 28, 2021
Online study of health professionals about their vaccination attitudes and behavior in the COVID-19 era: addressing participation biasPierre Verger, Dimitri Scronias, Yves Fradier, et al.Human Vaccines & Immunotherapeutics|June 9, 2021
Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysisAdoración Navarro-Torné, Eva Agostina Montuori, Vasiliki Kossyvaki, et al.Human Vaccines & Immunotherapeutics|July 13, 2021
Changes in general practitioners' attitudes toward COVID-19 vaccination after first interim results: a longitudinal approach in FrancePierre Verger, Dimitri ScroniasHuman Vaccines & Immunotherapeutics|June 11, 2021
A rational strategy to support approved COVID-19 vaccines prioritizationJavier Burgos-SalcedoHuman Vaccines & Immunotherapeutics|October 2, 2020
The co-presence of high-risk human papillomaviruses and Epstein-Barr virus is linked with tumor grade and stage in Qatari women with breast cancerIshita Gupta, Ayesha Jabeen, Reem Al-Sarraf, et al.Pageof 650